Researchers at the Israel Institute for Biological Research have successfully isolated a key coronavirus antibody, which is a significant step towards developing a vaccine for the virus, Israeli Defense Minister Naftali Bennett announced on Monday.

Bennett visited the institute on Monday, where he was briefed on “a significant breakthrough in finding an antidote for the coronavirus.”

The antibody “monoclonal,” which means it is derived from a single cell taken from the blood of a patient who recovered from COVID-19, can neutralize the disease-causing coronavirus inside carriers’ bodies, explained Bennett.

Antibodies from those who have successfully overcome the coronavirus are widely considered key to developing a possible cure for the virus.

Bennett said he was proud of the institute staff, and that “Jewish creativity and ingenuity brought about this amazing development.”

Institute director Shmuel Shapira said the antibody formula was being patented; afterwards, an international manufacturer will be sought to mass produce it.

Another Israeli research team at MigVax, an affiliate of MIGAL Galilee Research Institute, is reportedly close to completing its first phase of developing a COVID-19 vaccine and recently received an injection of $12 million to accelerate research.

Support Jewish Journalism
with 2020 Vision

One of the most intriguing stories of the sudden Coronavirus crisis is the role of the internet. With individuals forced into home quarantine, most are turning further online for information, education and social interaction.

JNS's influence and readership are growing exponentially, and our positioning sets us apart. Most Jewish media are advocating increasingly biased progressive political and social agendas. JNS is providing more and more readers with a welcome alternative and an ideological home.

During this crisis, JNS continues working overtime. We are being relied upon to tell the story of this crisis as it affects Israel and the global Jewish community, and explain the extraordinary political developments taking place in parallel.

Our ability to thrive in 2020 and beyond depends on the generosity of committed readers and supporters. Monthly donations in particular go a long way in helping us sustain our operations. We greatly appreciate any contributions you can make during these challenging times. We thank you for your ongoing support and wish you blessings for good health and peace of mind.